Daniel Speciale is the senior vice president of finance and the chief financial officer of the Specialty Generics business at Mallinckrodt Pharmaceuticals. He has responsibility for all controllership and investor relations activities for the company while leading the finance function for the Specialty Generics business. He serves as a member of Mallinckrodt’s finance and senior leadership teams.
Mr. Speciale joined Mallinckrodt in 2013 and has more than 17 years of experience in various accounting and finance roles. Prior to Mallinckrodt, Mr. Speciale held roles of increasing responsibility in the assurance practice of PricewaterhouseCoopers.
Mr. Speciale holds a bachelor’s and master’s degree in accountancy from the Gies College of Business at the University of Illinois at Champaign-Urbana and is a Certified Public Accountant (inactive).